Aspirin enhances antimetastatic immunity by decreasing platelet activation and releasing T cells from suppression by thromboxane A2.
Absolute Event Rate: 0% vs 0%
A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
Langley et al. (Wed,) reported a other. Aspirin enhances antimetastatic immunity by decreasing platelet activation and releasing T cells from suppression by thromboxane A2.